The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.
Outcome criteria in smoking cessation trials: proposal for a common standard
Abstract
Smoking cessation treatment is now integrated into many health-care systems and a major research effort is under way to improve current success rates. Until now results from randomized clinical trials have been reported in many different ways, leading to problems of interpretation. We propose six standard criteria comprising the 'Russell Standard' (RS). These criteria are applicable to trials of cessation aids where participants have a defined target quit date and there is face-to-face contact with researchers or clinic staff, as follows. (1) Follow-up for 6 months (RS6) or 12 months (RS12) from the target quit date or the end of a predefined 'grace period'; (2) self-report of smoking abstinence over the whole follow-up period allowing up to five cigarettes in total; (3) biochemical verification of abstinence at least at the 6-month or 12-month follow-up point; (4) use of an 'intention-to-treat' approach in which data from all randomized smokers are included in the analysis unless they have died or moved to an untraceable address (participants who are included in the analysis are counted as smokers if their smoking status at the final follow-up cannot be determined); (5) following-up 'protocol violators' and using their true smoking status in the analysis; and (6) collecting follow-up data blind to smokers' allocation to trial group. We believe that these criteria provide the best compromise between practicability and surrogacy for long-term cessation and will enable meaningful comparison between studies. There may be good reasons why other outcome criteria would also be reported, and studies that involve interventions with special groups or where there is no designated target quit date or face to face contact would need to adapt these criteria accordingly.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“authors like Benowitz et al. (2020) and West et al. (2005) suggest that abstinence outcomes are also reliable in those studies in which biochemical verification is not feasible, such as those in which the data are collected by phone or through the internet or when personal contact is limited.”
From Evaluation of effectiveness and acceptability of a psychological treatment for smoking cessation combined with a smartphone App: A pilot study (2024) · cites this paper as West et al., 2005
In the citing paper
“Study participants who (a) did not attend a follow-up visit, or (b) did not have a CO measurement, or (c) whose measured CO value exceeded the threshold of 9 ppm defined as critical (West et al., 2005) were classified as smokers.”
From Hypnotherapy compared to cognitive-behavioral therapy for smoking cessation in a randomized controlled trial (2024) · cites this paper as West et al., 2005
In the citing paper
“The primary outcome measure was 12 months continuous abstinence (CA) according to the Russell standard (West et al., 2005). This is defined as self-report of having smoked no more than five cigarettes since the end of treatment (and during all assessments 1, 6, 9, and 12 months later), supported by negative biochemical validation (CO < 10 ppm).”
From Hypnotherapy compared to cognitive-behavioral therapy for smoking cessation in a randomized controlled trial (2024) · cites this paper as West et al., 2005
In the citing paper
“In accordance with the Russell standard (West et al., 2005), a CO measurement of 10 or more parts per million was defined as indicative of current smoking.”
From Hypnotherapy compared to cognitive-behavioral therapy for smoking cessation in a randomized controlled trial (2024) · cites this paper as West et al., 2005
Citations
Cites
The Revised CONSORT Statement for Reporting Randomized Trials: Explanation and Elaboration
Altman, D. G., Schulz, K. F., Moher, D., Egger, M., Davidoff, F., Elbourne, D., Gøtzsche, P. C., Lang, T., & for the CONSORT Group (2001) · Annals of Internal Medicine · doi:10.7326/0003-4819-134-8-200104170-00012 · Cited by 3,835
A Comparison of Sustained-Release Bupropion and Placebo for Smoking Cessation
Hurt, R. D., Sachs, D. P. L., Glover, E. D., Offord, K. P., Johnston, J. A., Dale, L. C., Khayrallah, M. A., Schroeder, D. R., Glover, P. N., Sullivan, C. R., et al. (1997) · New England Journal of Medicine · doi:10.1056/nejm199710233371703 · Cited by 1,262
Measures of abstinence in clinical trials: issues and recommendations
Hughes, J. R., Keely, J. P., NIAURA, R. S., Ossip-Klein, D. J., RICHMOND, R. L., & Swan, G. E. (2003) · Nicotine & Tobacco Research · doi:10.1093/ntr/5.1.13 · Cited by 1,058
Interventions for promoting smoking cessation during pregnancy
Lumley, J., Chamberlain, C., Dowswell, T., Oliver, S., Oakley, L., & Watson, L. (2009) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001055.pub3 · Cited by 890
Treating Tobacco Use and Dependence
Goolsby, M. J. (2001) · Journal of the American Academy of Nurse Practitioners · doi:10.1111/j.1745-7599.2001.tb00227.x · Cited by 718
Measures of abstinence in clinical trials: issues and recommendations
Hughes, J. R., Keely, J. P., NIAURA, R. S., Ossip-Klein, D. J., RICHMOND, R. L., & Swan, G. E. (2003) · Nicotine & Tobacco Research · doi:10.1080/1462220031000070552 · Cited by 712
Interventions for promoting smoking cessation during pregnancy
Lumley, J., Oliver, S. R., Chamberlain, C., & Oakley, L. (2004) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001055.pub2 · Cited by 675
Lancaster, T. (2000) · BMJ · doi:10.1136/bmj.321.7257.355 · Cited by 565
Effect of nicotine chewing gum as an adjunct to general practitioner's advice against smoking.
Russell, M. A., Merriman, R., Stapleton, J., & Taylor, W. (1983) · BMJ · doi:10.1136/bmj.287.6407.1782 · Cited by 248
Self-citationProchaska, J. O., Velicer, W. F., Fava, J. L., Ruggiero, L., Laforge, R. G., Rossi, J. S., Johnson, S. S., & Lee, P. A. (2001) · Preventive Medicine · doi:10.1006/pmed.2000.0767 · Cited by 157
Cited by
Sorted by citations
Items 101–200 of 1,001
Müssener, U., Bendtsen, M., Karlsson, N. E., White, I. R., McCambridge, J., & Bendtsen, P. (2016) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2015.8260 · Cited by 104
“At baseline, participants were smoking a median (range) of 63 (1-238) and 70 (2-280)”
BackgroundBlack, N., Johnston, M., Michie, S., Hartmann‐Boyce, J., West, R., Viechtbauer, W., Eisma, M. C., Scott, C., & de Bruin, M. (2020) · Addiction · doi:10.1111/add.15056 · Cited by 111
“In essence, we combined a multi-level model (with random effects for studies and groups) [41] with a model that accounts for the depen-”
MethodSelf-citationCooper, S., Lewis, S., Thornton, J. G., Marlow, N., Watts, K., Britton, J., Grainge, M. J., Taggar, J., Essex, H., Parrott, S., et al. (2014) · Health Technology Assessment · doi:10.3310/hta18540 · Cited by 103
“Occasional minor lapses (no more than five cigarettes in total between the quit date and delivery) were not counted as a return to smoking; this is consistent with standard criteria for assessing outcome in cessation studies.(49) CO readings of ≤ 8 p.”
ResultMasaki, K., Tateno, H., Nomura, A., Muto, T., Suzuki, S., Satake, K., Hida, E., & Fukunaga, K. (2020) · npj Digital Medicine · doi:10.1038/s41746-020-0243-5 · Cited by 102
Exploring consensus on how to measure smoking cessation. A Delphi study
Cheung, K. L., de Ruijter, D., Hiligsmann, M., Elfeddali, I., Hoving, C., Evers, S., & de Vries, H. (2017) · BMC Public Health · doi:10.1186/s12889-017-4902-7 · Cited by 103
“This is consistent with the Russell standard (see Table 4), which recommends a follow-up of 6 or 12 months from the target quit date or the end of a predefined ‘grace period’ [11].”
BackgroundResultInfluentialGradual Versus Abrupt Smoking Cessation
Lindson, N., Banting, M., West, R., Michie, S., Shinkins, B., & Aveyard, P. N. (2016) · Annals of Internal Medicine · doi:10.7326/m14-2805 · Cited by 102
“Russell Standard abstinence is validated by an exhaled CO concentration of less than 10 ppm (17).”
MethodInfluentialSelf-citationMotives for smoking and their correlates in clients attending Stop Smoking treatment services
McEwen, A., West, R., & McRobbie, H. (2008) · Nicotine & Tobacco Research · doi:10.1080/14622200802027248 · Cited by 120
Self-citationTheodoulou, A., Chepkin, S. C., Ye, W., Fanshawe, T. R., Bullen, C., Hartmann‐Boyce, J., Livingstone‐Banks, J., Hajizadeh, A., & Lindson, N. (2023) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd013308.pub2 · Cited by 108
Liao, Y., Wu, Q., Kelly, B. C., Zhang, F., Tang, Y., Wang, Q., Ren, H., Hao, Y., Yang, M., Cohen, J. E., et al. (2018) · PLoS Medicine · doi:10.1371/journal.pmed.1002713 · Cited by 100
Nicotine receptor partial agonists for smoking cessation
Livingstone‐Banks, J., Fanshawe, T. R., Thomas, K. H., Theodoulou, A., Hajizadeh, A., Hartman, L., & Lindson, N. (2023) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006103.pub8 · Cited by 108
Carroll, K. M., Kiluk, B. D., Nich, C., DeVito, E. E., Decker, S. E., LaPaglia, D. M., Duffey, D. C., Babuscio, T. A., & Ball, S. A. (2014) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2014.01.012 · Cited by 99
“In nicotine research, prolonged abstinence and point-prevalence abstinence, with biochemical validation, are now standard measures for outcome trials (Hughes, 2007; Hughes et al., 2010; West et al., 2005).”
The impact of a lung cancer computed tomography screening result on smoking abstinence
van der Aalst, C. M., van Klaveren, R. J., van den Bergh, K. A. M., Willemsen, M. C., & de Koning, H. J. (2010) · European Respiratory Journal · doi:10.1183/09031936.00035410 · Cited by 99
Smit, E. S., de Vries, H., & Hoving, C. (2012) · Journal of Medical Internet Research · doi:10.2196/jmir.1812 · Cited by 97
“Although this is a recommended analysis when having to deal with dropout [37], replacing more than 70% of the values on the primary outcome measures might increase the chances of making a type II error [34,38].”
BackgroundResultInfluentialRedfern, J., Coorey, G., Mulley, J., Scaria, A., Neubeck, L., Hafiz, N., Pitt, C., Weir, K., Forbes, J., Parker, S., et al. (2020) · npj Digital Medicine · doi:10.1038/s41746-020-00325-z · Cited by 95
Ybarra, M. L., Holtrop, J. S., Prescott, T. L., Rahbar, M. H., & Strong, D. R. (2013) · Nicotine & Tobacco Research · doi:10.1093/ntr/nts339 · Cited by 94
Exercise interventions for smoking cessation
USSHER, M. H., Faulkner, G., Angus, K., Hartmann‐Boyce, J., & Taylor, A. H. (2019) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002295.pub6 · Cited by 99
Naughton, F., Jamison, J., Boase, S., Sloan, M., Gilbert, H., Prevost, A. T., Mason, D., Smith, S., Brimicombe, J., Evans, R., et al. (2014) · Addiction · doi:10.1111/add.12556 · Cited by 93
“In addition to pre-specified outcome measures, two longer-term smoking outcome measures were assessed [24]; 6-month prolonged abstinence at 6-month follow-up and a strict continuous abstinence measure using all outcome timepoints: CO-validated 2-week point prevalence abstinence at 4 weeks, 4-week point prevalence abst…”
MethodUSSHER, M. H., Kakar, G., Hájek, P., & West, R. (2015) · Addictive Behaviors · doi:10.1016/j.addbeh.2015.10.020 · Cited by 93
Self-citationBricker, J. B., Mull, K. E., McClure, J. B., Watson, N. L., & Heffner, J. L. (2018) · Addiction · doi:10.1111/add.14127 · Cited by 91
“0.89 (0.75, 1.06) 0.393 aOdds ratios are adjusted for the three factors used in stratified randomization: daily smoking frequency, education and gender; bcomplete case analysis (i.e. exclusion of participants lost to follow-up) was specified a priori as the primary outcome; cthe missing = smoking outcomes are provided…”
InfluentialHajek, P., Przulj, D., Pesola, F., Griffiths, C., Walton, R., McRobbie, H., Coleman, T., Lewis, S., Whitemore, R., Clark, M., et al. (2022) · Nature Medicine · doi:10.1038/s41591-022-01808-0 · Cited by 85
“The primary endpoint was prolonged abstinence from smoking from 2 weeks after the TQD until the end of pregnancy, defined as per Russell Standard 63 (up to five lapses allowed with no smoking at all during the previous week at the time of final follow-up).”
Interventions for smoking cessation and reduction in individuals with schizophrenia
Tsoi, D. T., Porwal, M., & Webster, A. C. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007253.pub3 · Cited by 304
Reid, R. D., Pipe, A., Quinlan, B., & Oda, J. (2007) · Patient Education and Counseling · doi:10.1016/j.pec.2007.01.005 · Cited by 90
Use of Varenicline for 4 Weeks Before Quitting Smoking
Hájek, P., McRobbie, H. J., Myers, K., Stapleton, J., & Dhanji, A. (2011) · Archives of Internal Medicine · doi:10.1001/archinternmed.2011.138 · Cited by 94
Self-citationPhillips, C., Syed, Y., Parthaláin, N. M., Reyer Zwiggelaar, A., Claypole, T. C., & Lewis, K. E. (2012) · Journal of Breath Research · doi:10.1088/1752-7155/6/3/036003 · Cited by 89
A test of motivational plus nicotine replacement interventions for HIV positive smokers
Ingersoll, K. S., Cropsey, K. L., & Heckman, C. J. (2009) · AIDS and Behavior · doi:10.1007/s10461-007-9334-4 · Cited by 86
Weekly versus basic smoking cessation support in primary care: a randomised controlled trial
Aveyard, P. N., Brown, K., Saunders, C., Alexander, A., Johnstone, E. C., Munafo, M. R., & Murphy, M. F. (2007) · Thorax · doi:10.1136/thx.2006.071837 · Cited by 88
Berlin, I., & Covey, L. S. (2006) · Addiction · doi:10.1111/j.1360-0443.2006.01616.x · Cited by 89
Twardella, D., & Brenner, H. (2007) · Tobacco Control · doi:10.1136/tc.2006.016253 · Cited by 84
Strategies to improve smoking cessation rates in primary care
Lindson, N., Pritchard, G., Hong, B., Fanshawe, T. R., Pipe, A., & Papadakis, S. (2021) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd011556.pub2 · Cited by 89
Cytisinicline for Smoking Cessation
Rigotti, N. A., Benowitz, N. L., Prochaska, J. J., Leischow, S. J., Nides, M. A., Blumenstein, B. A., Clarke, A., Cain, D. F., & Jacobs, C. A. (2023) · JAMA · doi:10.1001/jama.2023.10042 · Cited by 98
Walker, N. K., Howe, C., Bullen, C., Grigg, M., Glover, M., McRobbie, H. J., Laugesen, M., Parag, V., & Whittaker, R. (2012) · Addiction · doi:10.1111/j.1360-0443.2012.03906.x · Cited by 85
Kanera, I. M., Bolman, C. A. W., Willems, R. A., Mesters, I., & Lechner, L. (2016) · Journal of Cancer Survivorship · doi:10.1007/s11764-016-0535-6 · Cited by 85
“With regard to smoking outcomes, for ITT, participants who were identified as smokers at baseline were accounted as smokers if their smoking status after 6 months could not be determined [83].”
BackgroundPharmacological interventions for promoting smoking cessation during pregnancy
Claire, R., Chamberlain, C., Davey, M.-A., Cooper, S. E., Berlin, I., Leonardi-Bee, J., & Coleman, T. (2020) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010078.pub3 · Cited by 188
Yoong, S. L., Stockings, E., Chai, L. K., Tzelepis, F., Wiggers, J. H., Oldmeadow, C. J., Paul, C. L., Peruga, A., Kingsland, M., Attia, J., et al. (2018) · Australian and New Zealand Journal of Public Health · doi:10.1111/1753-6405.12777 · Cited by 84
Wang, M. P., Luk, T. T., Wu, Y., Li, W. H., Cheung, D. Y., Kwong, A. C., Lai, V., Chan, S. S., & Lam, T. H. (2019) · The Lancet Digital Health · doi:10.1016/s2589-7500(19)30082-2 · Cited by 78
CHRNA3 rs1051730 Genotype and Short-Term Smoking Cessation
Munafo, M. R., Johnstone, E. C., Walther, D. M., Uhl, G. R., Murphy, M. F. G., & Aveyard, P. N. (2011) · Nicotine & Tobacco Research · doi:10.1093/ntr/ntr106 · Cited by 82
Naughton, F., Cooper, S. E., Foster, K. A., Emery, J. L., Leonardi‐Bee, J., Sutton, S. R., Jones, M., USSHER, M. H., Whitemore, R., Leighton, M., et al. (2017) · Addiction · doi:10.1111/add.13802 · Cited by 83
“However, we assumed conservatively that women lost to follow-up were still smoking [27] and outcome ascertainment rates were slightly higher in the usual care group; both factors would tend to attenuate rather than inflate the observed intervention effect.”
InfluentialDepression and smoking cessation: evidence from a smoking cessation clinic with 1-year follow-up
Stepankova, L., Kralikova, E., Zvolska, K., Pankova, A., Ovesna, P., Blaha, M., & Brose, L. S. (2017) · Annals of Behavioral Medicine · doi:10.1007/s12160-016-9869-6 · Cited by 78
“Patients lost to follow-up despite multiple attempts at contact (15%) were recorded as not abstinent [30].”
West, R., Evins, A. E., Benowitz, N. L., Russ, C., McRae, T. D., Lawrence, D., Aubin, L. S., Krishen, A., Maravić, M. C., & Anthenelli, R. M. (2018) · Addiction · doi:10.1111/add.14208 · Cited by 82
“We used weeks 9–24 (a period that includes the last 4 weeks of treatment and 12-week non-treatment follow-up) as this provided a measure that is closest to the Russell Standard, the recommended end-point to ensure greatest confidence in extrapolating to life-time abstinence [26].”
MethodSelf-citationSmith, K. M., Phillips‐Waller, A., Pesola, F., McRobbie, H. J., Przulj, D., Orzol, M., & Hájek, P. (2021) · Addiction · doi:10.1111/add.15628 · Cited by 85
“Participants lost to follow up were classified as non-abstainers/non-reducers as per Russell standard (17).”
BackgroundMethodGarrison, K. A., Pal, P., Rojiani, R., Dallery, J., O’Malley, S. S., & Brewer, J. A. (2015) · BMC Psychiatry · doi:10.1186/s12888-015-0468-z · Cited by 74
“This trial will use an intention-to-treat approach [30].”
BackgroundMethodLüscher, J., Stadler, G., Ochsner, S., Rackow, P., Knoll, N., Hornung, R., & Scholz, U. (2015) · British Journal of Health Psychology · doi:10.1111/bjhp.12135 · Cited by 79
Impact of institutional smoking bans on reducing harms and secondhand smoke exposure
Frazer, K., McHugh, J., Callinan, J., & Kelleher, C. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd011856.pub2 · Cited by 79
Leaviss, J., Sullivan, W., Ren, S., Everson-Hock, E., Stevenson, M., Stevens, J., Strong, M., & Cantrell, A. J. (2014) · Health Technology Assessment · doi:10.3310/hta18330 · Cited by 78
Tsoi, D. T.-Y., Porwal, M., & Webster, A. C. (2010) · The British Journal of Psychiatry · doi:10.1192/bjp.bp.109.066019 · Cited by 77
(2010) · Wiley eBooks · doi:10.1002/9781444318852 · Cited by 79
Bartlett, Y. K., Sheeran, P., & Hawley, M. (2013) · British Journal of Health Psychology · doi:10.1111/bjhp.12071 · Cited by 81
Gould, G., McEwen, A., Watters, T., Clough, A. R., & van der Zwan, R. (2012) · Tobacco Control · doi:10.1136/tobaccocontrol-2012-050436 · Cited by 81
“27 29 31 35 38 41 42 Standardised reporting of smoking abstinence, which is considered best practice, was missing from most of the studies.(47) 48 Only three studies described how they assessed self-reported quit status: consumption over the last 7 days,(26) 29 38 while three studies biochemically validated abstinence…”
MethodBaskerville, N. B., Dash, D., Shuh, A., Wong, K., Abramowicz, A., Yessis, J. L., & Kennedy, R. D. (2017) · Preventive Medicine Reports · doi:10.1016/j.pmedr.2017.02.004 · Cited by 78
“Consistency in the reporting of outcomes (Copley et al., 2006;West et al., 2005) greatly assists in the review of evidence and decision-making on the effectiveness of interventions.”
BackgroundWalker, N. K., Smith, B. D., Barnes, J., Verbiest, M. E. A., Parag, V., Pokhrel, S., Wharakura, M., Lees, T., Gutierrez, H. C., Jones, B., et al. (2021) · Addiction · doi:10.1111/add.15489 · Cited by 82
“prevalence abstinence (no cigarettes, not a single puff, in the previous 7 days) [27]; time to first cigarette smoked from the quit date, even a single puff (lapse); time to first relapse (time to smoking more than five cigarettes a day for 3 or more days in a row); number of cigarettes smoked”
BackgroundMethodCarpenter, M. J., Wahlquist, A. E., Dahne, J., Gray, K. M., Cummings, K. M., Warren, G. W., Wagener, T. L., Goniewicz, M. L., & Smith, T. T. (2023) · EClinicalMedicine · doi:10.1016/j.eclinm.2023.102142 · Cited by 75
van der Aalst, C. M., de Koning, H. J., van den Bergh, K. A. M., Willemsen, M. C., & van Klaveren, R. J. (2011) · Lung Cancer · doi:10.1016/j.lungcan.2011.10.006 · Cited by 75
Cognitive Determinants of Health Behavior
Conner, M. T. (2010) · Springer eBooks · doi:10.1007/978-0-387-09488-5_2 · Cited by 80
Cooper, S., Taggar, J., Lewis, S., Marlow, N., Dickinson, A., Whitemore, R., & Coleman, T. (2014) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(14)70157-2 · Cited by 73
A Preliminary Benefit-Risk Assessment of Varenicline in Smoking Cessation
Cahill, K., Stead, L. F., & Lancaster, T. (2009) · Drug Safety · doi:10.2165/00002018-200932020-00005 · Cited by 73
Self-citationPeterson, A. V., Kealey, K. A., Mann, S. L., Marek, P. M., Ludman, E. J., Liu, J., & Bricker, J. B. (2009) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djp317 · Cited by 73
Gold Standard Program for Heavy Smokers in a Real-Life Setting
Neumann, T., Rasmussen, M., Heitmann, B. L., & Tønnesen, H. (2013) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph10094186 · Cited by 73
“To compare the results from this observational prospective study with results from randomized controlled studies, the abstinence was reported according to the Russell criteria [28], assuming in the worst case that all non-responders had relapsed.”
ResultO’Connell, G., Graff, D. W., & D’Ruiz, C. D. (2016) · Toxicology Mechanisms and Methods · doi:10.1080/15376516.2016.1196282 · Cited by 73
“…NO following smoking cessation (Chambers et al., 1998; Hogman et al., 2002; Jarvis et al., 1980; Malinovschi et al., 2006; Ripoll et al., 2012; Robbins et al., 1997; West et al., 2005; Yates et al., 2001); both of which may be indicative of immediate and future physiological benefits to the smoker.”
BackgroundResultD’Ruiz, C. D., O'Connell, G., Graff, D. W., & Yan, X. (2017) · Regulatory Toxicology and Pharmacology · doi:10.1016/j.yrtph.2017.05.002 · Cited by 73
Louwagie, G. M. C., Okuyemi, K. S., & Ayo‐Yusuf, O. A. (2014) · Addiction · doi:10.1111/add.12671 · Cited by 72
Hajek, P., Phillips-Waller, A., Przulj, D., Pesola, F., Smith, K. M., Bisal, N., Li, J., Parrott, S., Sasieni, P., Dawkins, L., et al. (2019) · Health Technology Assessment · doi:10.3310/hta23430 · Cited by 72
Pharmacological interventions for promoting smoking cessation during pregnancy
Coleman, T., Chamberlain, C., Davey, M.-A., Cooper, S. E., & Leonardi-Bee, J. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010078.pub2 · Cited by 357
Current and Emerging Pharmacotherapies for Cessation of Tobacco Smoking
Gómez‐Coronado, N., Walker, A. J., Berk, M., & Dodd, S. (2017) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.2073 · Cited by 74
“We found that the approaches used to report on outcomes of randomized clinical trials varied greatly.(6) The lack of standard criteria may hinder understanding and comparing those results.”
MethodBaskerville, N. B., Struik, L. L., Guindon, G. E., Norman, C. D., Whittaker, R., Burns, C. M., Hammond, D. G., Dash, D., & Brown, K. S. (2018) · JMIR mhealth and uhealth · doi:10.2196/10893 · Cited by 75
“The intention-to-treat principle was followed for the analysis of continuous abstinence and the outcomes 30-day and 7-day PPA using 3 approaches to handle missing information about smoking status: (1) imputation using the baseline observation carried forward or classifying nonresponders at 3 and 6 months as smokers in…”
Hiscock, R., Murray, S., Brose, L. S., McEwen, A., Bee, J. L., Dobbie, F., & Bauld, L. (2013) · Addictive Behaviors · doi:10.1016/j.addbeh.2013.07.010 · Cited by 70
Dorner, T. E., Trostl, A., Womastek, I., & Groman, E. (2011) · Nicotine & Tobacco Research · doi:10.1093/ntr/ntr179 · Cited by 71
Interventions for smoking cessation and reduction in individuals with schizophrenia
Tsoi, D. T.-Y., Porwal, M., & Webster, A. C. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007253.pub2 · Cited by 73
Vaccination against nicotine: an emerging therapy for tobacco dependence
Maurer, P., & Bachmann, M. F. (2007) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.16.11.1775 · Cited by 70
Taylor, G. M. J., Itani, T., Thomas, K. H., Rai, D., Jones, T., Windmeijer, F., Martin, R. M., Munafò, M. R., Davies, N. M., & Taylor, A. E. (2020) · Nicotine & Tobacco Research · doi:10.1093/ntr/ntz072 · Cited by 68
Carim-Todd, L., Mitchell, S. H., & Oken, B. S. (2013) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2013.04.014 · Cited by 82
Holliday, R., Preshaw, P. M., Ryan, V., Sniehotta, F. F., McDonald, S., Bauld, L., & McColl, E. (2019) · Pilot and Feasibility Studies · doi:10.1186/s40814-019-0451-4 · Cited by 69
Nicotine receptor partial agonists for smoking cessation
Livingstone‐Banks, J., Fanshawe, T. R., Thomas, K. H., Theodoulou, A., Hajizadeh, A., Hartman, L., & Lindson, N. (2023) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006103.pub9 · Cited by 77
van den Brand, F. A., Nagelhout, G. E., Winkens, B., Chavannes, N. H., & van Schayck, O. C. P. (2018) · The Lancet Public Health · doi:10.1016/s2468-2667(18)30185-3 · Cited by 70
Doyle, F., Rohde, D., Rutkowska, A., Morgan, K., Cousins, G., & McGee, H. M. (2013) · Psychosomatic Medicine · doi:10.1097/psy.0000000000000020 · Cited by 67
Association of COMT Val108/158Met genotype with smoking cessation
Munafò, M. R., Johnstone, E. C., Guo, B., Murphy, M. F. G., & Aveyard, P. (2008) · Pharmacogenetics and Genomics · doi:10.1097/fpc.0b013e3282f44daa · Cited by 68
Combining smoking cessation interventions with LDCT lung cancer screening: A systematic review
Iaccarino, J. M., Duran, C., Slatore, C. G., Wiener, R. S., & Kathuria, H. (2019) · Preventive Medicine · doi:10.1016/j.ypmed.2019.02.016 · Cited by 68
McEwen, A., West, R., & McRobbie, H. (2006) · Addictive Behaviors · doi:10.1016/j.addbeh.2005.12.014 · Cited by 67
Self-citationSmoking Cessation in the ITALUNG Lung Cancer Screening: What Does “Teachable Moment” Mean?
Pistelli, F., Aquilini, F., Falaschi, F., Puliti, D., Ocello, C., Pegna, A. L., Carozzi, F. M., Picozzi, G., Zappa, M., Mascalchi, M., et al. (2019) · Nicotine & Tobacco Research · doi:10.1093/ntr/ntz148 · Cited by 67
Interventions for recruiting smokers into cessation programmes
Belisario, J. S. M., Bruggeling, M. N., Gunn, L. H., Brusamento, S., & Car, J. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009187.pub2 · Cited by 72
Redfern, J., Usherwood, T. P., Harris, M., Rodgers, A., Hayman, N. E., Panaretto, K. S., Chow, C. K., Lau, A. Y. S., Neubeck, L., Coorey, G., et al. (2014) · BMJ Open · doi:10.1136/bmjopen-2013-004523 · Cited by 67
Thyrian, J. R., Panagiotakos, D. B., Polychronopoulos, E., West, R., Zatoński, W. A., & John, U. (2008) · BMC Public Health · doi:10.1186/1471-2458-8-2 · Cited by 68
Self-citationScheuermann, T. S., Richter, K. P., Rigotti, N. A., Cummins, S. E., Harrington, K. F., Sherman, S. E., Zhu, S., Tindle, H. A., & Preacher, K. J. (2017) · Addiction · doi:10.1111/add.13913 · Cited by 67
“Assessing smoking abstinence is a challenge for smoking cessation trials [1,2].”
Stapleton, J., West, R., Hájek, P., Wheeler, J., Vangeli, E., Abdi, Z., OʼGara, C., McRobbie, H. J., Humphrey, K., Ali, R. J., et al. (2013) · Addiction · doi:10.1111/add.12304 · Cited by 66
“By definition, all those classified as RS6 abstinent were also DH4 and PP6 abstinent.”
BackgroundMethodInfluentialSelf-citationD’Ruiz, C. D., Graff, D. W., & Robinson, E. (2016) · BMC Public Health · doi:10.1186/s12889-016-3236-1 · Cited by 65
“Moreover, the study findings associated with exhaled breath biomarkers in the cessation and exclusive use groups were consistent with other research findings associated with reductions in exhaled CO and increases in NO following smoking cessation [28–35]; both of which are indicative of immediate and future health ben…”
ResultPhysical activity for smoking cessation in pregnancy: randomised controlled trial
USSHER, M. H., Lewis, S., Aveyard, P. N., Manyonda, I., West, R., Lewis, B. A., Marcus, B. H., Riaz, M. A., Taylor, A. H., Daley, A., et al. (2015) · BMJ · doi:10.1136/bmj.h2145 · Cited by 66
“25 Using logistic regression we compared the proportion of women reporting continuous smoking abstinence at the end of pregnancy between study groups, with adjustment for recruitment centre.”
MethodSelf-citationNollen, N. L., Mayo, M. S., Sanderson Cox, L., Benowitz, N. L., Tyndale, R. F., Ellerbeck, E. F., Scheuermann, T. S., & Ahluwalia, J. S. (2019) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djz001 · Cited by 62
“Participants who had missing outcome data at weeks 4, 12, and 26 were considered smokers per the Russell Standard (90).”
MethodMobile applications for the treatment of tobacco use and dependence
Vilardaga, R., Casellas-Pujol, E., McClernon, J. F., & Garrison, K. A. (2019) · Current Addiction Reports · doi:10.1007/s40429-019-00248-0 · Cited by 64
Ferguson, J., Docherty, G., Bauld, L., Lewis, S., Lorgelly, P. K., Boyd, K., McEwen, A., & Coleman, T. J. (2012) · BMJ · doi:10.1136/bmj.e1696 · Cited by 63
Gulliver, A., Farrer, L. M., Chan, J. K., Tait, R. J., Bennett, K., Calear, A. L., & Griffiths, K. M. (2015) · Addiction Science & Clinical Practice · doi:10.1186/s13722-015-0027-4 · Cited by 63
“Given that abstinence is regarded as the benchmark for smoking cessation interventions [50], the metaanalysis examined tobacco interventions that used abstinence as an outcome measure and included a control group (n = 6).”
MethodMacLaren, D. J., Conigrave, K. M., Robertson, J. A., Ivers, R. G., Eades, S., & CLOUGH, A. R. (2010) · Population Health Metrics · doi:10.1186/1478-7954-8-2 · Cited by 63
“Data were included in the analysis if: (i) self-reported smokers reported smoking tobacco within the preceding 24 hours; or (ii) self-reported nonsmokers reported never smoking tobacco or not smoking tobacco for ≥6 months[43].”
MethodEffect of exercise type on smoking cessation: a meta-analysis of randomized controlled trials
Klinsophon, T., Thaveeratitham, P., Sitthipornvorakul, E., & Janwantanakul, P. (2017) · BMC Research Notes · doi:10.1186/s13104-017-2762-y · Cited by 63
“Continuous abstinence corresponded more closely to the treatment goal [72].”
MethodAn uncontrolled trial of cytisine (Tabex) for smoking cessation: Table 1
Zatoński, W. A., Cedzyńska, M., Tutka, P., & West, R. (2006) · Tobacco Control · doi:10.1136/tc.2006.016097 · Cited by 61
Self-citationElfeddali, I., Bolman, C. A. W., Candel, M. J. J. M., Wiers, R. W. H. J., & de Vries, H. (2011) · British Journal of Health Psychology · doi:10.1111/j.2044-8287.2011.02032.x · Cited by 63
“This definition of relapse conforms to the Russell Standard (West et al. , 2005).”
BackgroundMethodRandomized controlled trial of a social support (‘buddy’) intervention for smoking cessation
May, S., West, R., Hájek, P., McEwen, A., & McRobbie, H. J. (2006) · Patient Education and Counseling · doi:10.1016/j.pec.2006.02.008 · Cited by 61
Self-citationThe Missing=Smoking Assumption: A Fallacy in Internet-Based Smoking Cessation Trials?
Blankers, M., Smit, E. S., van der Pol, P., de Vries, H., Hoving, C., & van Laar, M. (2015) · Nicotine & Tobacco Research · doi:10.1093/ntr/ntv055 · Cited by 61
A Randomized Trial of Motivational Interviewing
Catley, D., Goggin, K., Harris, K. J., Richter, K. P., Williams, K. B., Patten, C. A., Resnicow, K., Ellerbeck, E. F., Bradley‐Ewing, A., Lee, H. S., et al. (2015) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2015.10.013 · Cited by 61
O’Connor, M., Whelan, R., Bricker, J., & McHugh, L. (2020) · Behavior Therapy · doi:10.1016/j.beth.2019.06.003 · Cited by 55
Needle Trap Device-GC-MS for Characterization of Lung Diseases Based on Breath VOC Profiles
Monedeiro, F., Monedeiro-Milanowski, M., Ratiu, I., Brożek, B., Ligor, T., & Buszewski, B. (2021) · Molecules · doi:10.3390/molecules26061789 · Cited by 60
Lawrence, M., Kerr, S., McVey, C., & Godwin, J. (2012) · International Journal of Stroke · doi:10.1111/j.1747-4949.2012.00771.x · Cited by 60
Smoking reduction interventions for smoking cessation
Lindson, N., Klemperer, E. M., & Aveyard, P. N. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd013183 · Cited by 60
Metadata
- Authors
- West, R., Hajek, P., Stead, L., & Stapleton, J.
- Affiliations
- University College London (GB)
- University of Oxford (GB)
- King's College London (GB)
- Corresponding author
- West, Robert
- ORCID
- West, Robert
- Venue
- Addiction
- Publisher
- Wiley
- Published
- 2005-03
- Volume
- 100
- Issue
- 3
- Pages
- 299-303
- ISSN
- 0965-2140 (ISSN-L)
- 1360-0443
- OpenAlex
- W2138106394
- Cited by
- 1,285
- References
- 15
- Citations by year
- 2026: 38 · 2025: 68 · 2024: 84 · 2023: 77 · 2022: 79 · 2021: 69 · 2020: 75 · 2019: 85 · 2018: 58 · 2017: 84 · 2016: 64 · 2015: 77 · 2014: 67 · 2013: 70 · 2012: 56
- FWCI
- 17.98
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Addiction (publishedVersion)
- PubMed (publishedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Smoking Behavior and Cessation
- Physical Sciences › Mathematics › Statistics and Probability › Statistical Methods in Clinical Trials
- Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
- Keywords
- smoking cessation, outcome criteria, cessation aids, smoking abstinence, intention-to-treat analysis, grace period, trial comparability
- MeSH terms
- Humans, Research Design, Randomized Controlled Trials as Topic, Smoking Cessation, Outcome Assessment, Health Care
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review